x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DCL-001241
| Product Information | |
|---|---|
| Organism | Mouse |
| Tissue | Inguinal subcutaneous fat depot |
| Cell Type | Fat cells |
| Phenotype | Fibroblast-like |
| Product Description | The X9 is one of beige clones, showing evidence that previously identified brown fat deposits in adult humans are composed of beige adipocytes offering a foundation for studying this mammalian cell type with therapeutic potential for the epidemic of obesity and diabetes. |
| Format | Frozen |
| Growth Properties | Adherent |
| Shipping & Storage | |
|---|---|
| Shipping | Cryopreserved on dry ice. |
| Storage Instructions | 37 °C, 95% Air, 5% CO2. Store in vapor phase of liquid nitrogen. |
| Storage Buffer/Media | The base medium for this cell line is DMEM/F12 containing 2.5 mM L-glutamine, 15 mM HEPES, 0.5 mM sodium pyruvate, and 1200 mg/L sodium bicarbonate. To make the complete growth medium, add the following components to the base medium: 15%, FBS; L-Alanyl-L-Glutamine final concentration of 2.36 mM. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
